245 related articles for article (PubMed ID: 25205547)
1. Combined immunodeficiency evolving into predominant CD4+ lymphopenia caused by somatic chimerism in JAK3.
Ban SA; Salzer E; Eibl MM; Linder A; Geier CB; Santos-Valente E; Garncarz W; Lion T; Ott R; Seelbach C; Boztug K; Wolf HM
J Clin Immunol; 2014 Nov; 34(8):941-53. PubMed ID: 25205547
[TBL] [Abstract][Full Text] [Related]
2. A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency.
Khanolkar A; Wilks JD; Liu G; Simpson BM; Caparelli EA; Kirschmann DA; Bergerson J; Fuleihan RL
Immunol Res; 2020 Feb; 68(1):13-27. PubMed ID: 32215810
[TBL] [Abstract][Full Text] [Related]
3. Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment.
Cattaneo F; Recher M; Masneri S; Baxi SN; Fiorini C; Antonelli F; Wysocki CA; Calderon JG; Eibel H; Smith AR; Bonilla FA; Tsitsikov E; Giliani S; Notarangelo LD; Pai SY
J Allergy Clin Immunol; 2013 Apr; 131(4):1136-45. PubMed ID: 23384681
[TBL] [Abstract][Full Text] [Related]
4. Atypical immune phenotype in severe combined immunodeficiency patients with novel mutations in IL2RG and JAK3.
Goldberg L; Simon AJ; Lev A; Barel O; Stauber T; Kunik V; Rechavi G; Somech R
Genes Immun; 2020 Nov; 21(5):326-334. PubMed ID: 32921793
[TBL] [Abstract][Full Text] [Related]
5. Omenn Syndrome in Two Infants with Different Hypomorphic Variants in Janus Kinase 3.
Tsilifis C; Spegarova JS; Good R; Griffin H; Engelhardt KR; Graham S; Hughes S; Arkwright PD; Hambleton S; Gennery AR
J Clin Immunol; 2024 Apr; 44(4):98. PubMed ID: 38598033
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation in the JH4 domain of JAK3 causing severe combined immunodeficiency complicated by vertebral osteomyelitis.
Qamar F; Junejo S; Qureshi S; Seleman M; Bainter W; Massaad M; Chou J; Geha RS
Clin Immunol; 2017 Oct; 183():198-200. PubMed ID: 28917720
[TBL] [Abstract][Full Text] [Related]
7. Unexpected and variable phenotypes in a family with JAK3 deficiency.
Frucht DM; Gadina M; Jagadeesh GJ; Aksentijevich I; Takada K; Bleesing JJ; Nelson J; Muul LM; Perham G; Morgan G; Gerritsen EJ; Schumacher RF; Mella P; Veys PA; Fleisher TA; Kaminski ER; Notarangelo LD; O'Shea JJ; Candotti F
Genes Immun; 2001 Dec; 2(8):422-32. PubMed ID: 11781709
[TBL] [Abstract][Full Text] [Related]
8. Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association.
Yee CS; Massaad MJ; Bainter W; Ohsumi TK; Föger N; Chan AC; Akarsu NA; Aytekin C; Ayvaz DÇ; Tezcan I; Sanal Ö; Geha RS; Chou J
J Allergy Clin Immunol; 2016 Mar; 137(3):879-88.e2. PubMed ID: 26476480
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray.
Bayer DK; Martinez CA; Sorte HS; Forbes LR; Demmler-Harrison GJ; Hanson IC; Pearson NM; Noroski LM; Zaki SR; Bellini WJ; Leduc MS; Yang Y; Eng CM; Patel A; Rodningen OK; Muzny DM; Gibbs RA; Campbell IM; Shaw CA; Baker MW; Zhang V; Lupski JR; Orange JS; Seeborg FO; Stray-Pedersen A
Clin Exp Immunol; 2014 Dec; 178(3):459-69. PubMed ID: 25046553
[TBL] [Abstract][Full Text] [Related]
10. Whole-exome sequencing of T
El Hawary R; Meshaal S; Mauracher AA; Opitz L; Abd Elaziz D; Lotfy S; Eldash A; Boutros J; Galal N; Pachlopnik Schmid J; Elmarsafy A
Clin Exp Immunol; 2021 Mar; 203(3):448-457. PubMed ID: 33040328
[TBL] [Abstract][Full Text] [Related]
11. Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.
Okuno Y; Hoshino A; Muramatsu H; Kawashima N; Wang X; Yoshida K; Wada T; Gunji M; Toma T; Kato T; Shiraishi Y; Iwata A; Hori T; Kitoh T; Chiba K; Tanaka H; Sanada M; Takahashi Y; Nonoyama S; Ito M; Miyano S; Ogawa S; Kojima S; Kanegane H
J Clin Immunol; 2015 Oct; 35(7):610-4. PubMed ID: 26407811
[TBL] [Abstract][Full Text] [Related]
12. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
Roifman CM; Zhang J; Chitayat D; Sharfe N
Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514
[TBL] [Abstract][Full Text] [Related]
13. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
[TBL] [Abstract][Full Text] [Related]
14. JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.
Di Matteo G; Chiriaco M; Scarselli A; Cifaldi C; Livadiotti S; Di Cesare S; Ferradini V; Aiuti A; Rossi P; Finocchi A; Cancrini C
Mol Genet Genomic Med; 2018 Sep; 6(5):713-721. PubMed ID: 30032486
[TBL] [Abstract][Full Text] [Related]
15. FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells.
Rani A; Greenlaw R; Runglall M; Jurcevic S; John S
PLoS One; 2014; 9(2):e90370. PubMed ID: 24587342
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional basis for JAK3-deficient severe combined immunodeficiency.
Candotti F; Oakes SA; Johnston JA; Giliani S; Schumacher RF; Mella P; Fiorini M; Ugazio AG; Badolato R; Notarangelo LD; Bozzi F; Macchi P; Strina D; Vezzoni P; Blaese RM; O'Shea JJ; Villa A
Blood; 1997 Nov; 90(10):3996-4003. PubMed ID: 9354668
[TBL] [Abstract][Full Text] [Related]
17. Consequences of a mutation in the UNC119 gene for T cell function in idiopathic CD4 lymphopenia.
Gorska MM; Alam R
Curr Allergy Asthma Rep; 2012 Oct; 12(5):396-401. PubMed ID: 22729960
[TBL] [Abstract][Full Text] [Related]
18. Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors.
Haan C; Rolvering C; Raulf F; Kapp M; Drückes P; Thoma G; Behrmann I; Zerwes HG
Chem Biol; 2011 Mar; 18(3):314-23. PubMed ID: 21439476
[TBL] [Abstract][Full Text] [Related]
19. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ
Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768
[TBL] [Abstract][Full Text] [Related]
20. Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting.
Chang CW; Lai YS; Westin E; Khodadadi-Jamayran A; Pawlik KM; Lamb LS; Goldman FD; Townes TM
Cell Rep; 2015 Sep; 12(10):1668-77. PubMed ID: 26321643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
